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Proposing the VetCompass clinical 
grading tool for heat‑related illness 
in dogs
Emily J. Hall1*, Anne J. Carter1, Jude Bradbury1, Dominic Barfield2 & Dan G. O’Neill3 
Heat‑related illness is a potentially fatal condition in dogs. Rapid and accurate recognition of the 
severity can improve clinical management in affected dogs and lead to better outcomes. This study 
explored retrospective VetCompass veterinary clinical records to investigate the clinical signs recorded 
for dogs presenting with heat‑related illness to primary‑care veterinary practice from 2016 to 2018. 
The relative risk of death associated with these clinical signs was reported and used to develop a novel 
clinical grading tool. From the clinical records of 856 heat‑related illness events, the most frequently 
recorded clinical signs were respiratory changes (68.73%) and lethargy (47.79%). The clinical signs with 
the highest relative risk of death were neurological dysfunction, gastrointestinal haemorrhage and 
bleeding disorders. The novel VetCompass Clinical Grading Tool for Heat‑Related Illness in dogs defines 
three grades: mild (altered respiration, lethargy), moderate (gastrointestinal signs, a single seizure, 
episodic collapse) and severe (neurological dysfunction, gastrointestinal haemorrhage, bleeding 
disorders). This novel grading tool offers a simple, evidence‑based device to improve recognition of 
heat‑related illness in dogs and promote improved decision‑making for earlier interventions such as 
cooling and hospitalisation. This could improve outcomes and protect the welfare of dogs in the face 
of rising global temperatures.
Abbreviations
CI  Confidence interval
EPR  Electronic patient record
HRI  Heat related illness
Heat-related illness (HRI) is a potentially fatal disorder that affects dogs when their thermoregulatory capacity 
is overwhelmed, resulting in hyperthermia and subsequent thermal tissue  damage1,2. There are three recognised 
main triggers (though with some overlap) of HRI in dogs; exertional HRI occurs following exercise in a hot 
environment or following intense  activity2,3, environmental HRI results from exposure to extreme environmental 
heat or prolonged exposure to a hot  environment1,4, and vehicular HRI results from either entrapment or travel 
in a hot  vehicle3. Both dogs and humans show differing risks for each HRI trigger according to their age, sex, 
and underlying health status. Young, active male  humans5 and  dogs3 are at particular risk of exertional HRI, 
with breeds including the Labrador Retriever, Golden Retriever, Springer Spaniel and Staffordshire Bull Terrier 
at greater risk than crossbred  dogs3. Older dogs and humans have increased risk of environmental  HRI3,6, in 
part because elderly individuals are more likely to have underlying health conditions such as respiratory disease 
and heart  failure7. Additionally, age-related physiological changes reduce peripheral blood flow and sweat gland 
function, and thereby limit the effectiveness of homeostatic thermoregulatory functions for effective cooling 
in older  individuals8. Vehicular HRI particularly affects young children and babies, most frequently following 
accidental  entrapment9. Vehicular HRI can also affect dogs, but brachycephalic (flat-faced) breeds such as the 
British Bulldog, Pug and French Bulldog appear particularly  susceptible3, likely because of their inherently 
reduced ability to thermoregulate resulting from their shortened muzzle and narrowed  airways10.
The diagnosis of HRI in human medicine traditionally relies upon measurement of body temperature and 
assessment of neurological function using the “Classical” definitions established by Bouchama and  Knochel1. 
These Classical Heat Stroke Criteria define three levels of HRI, rising from mild heat stress (perceived discom-
fort and physiological strain resulting from mild hyperthermia), to heat exhaustion (moderate illness including 
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weakness, anxiety, fainting, headache and a core temperature that may be elevated up to, but not exceeding 40 °C) 
and finally heat stroke (severe illness, body temperature exceeding 40 °C accompanied by profound neurological 
dysfunction including delirium, seizures and coma)1. These classical criteria, using a body temperature threshold 
of ≥ 41 °C, are also used in veterinary medicine for diagnosing and categorising HRI in animals, most frequently 
 dogs2,11,12, despite their reliance upon clinical signs/symptoms that, in humans, require verbal communication 
from the patient e.g. headache, dizziness, anxiety and delirium. However, a study of experimentally induced heat 
stroke in dogs reported 43 °C as the critical body temperature threshold for inducing clinical, haematological, 
biochemical and pathological indicators of heat-related illness in  dogs13. The duration that the dog’s body tem-
perature exceeded 43 °C accurately predicted the risk of  death13. The lack of consensus in the veterinary literature 
regarding the critical temperature threshold for HRI in dogs highlights uncertainty in the value and reliability 
of using body temperature as a diagnostic criterion for HRI.
Following recognition of the limitations from using core body temperature measurement as a diagnostic 
criterion for the Classical Heat Stroke Criteria in human medicine, a novel HRI staging system was proposed but 
has not yet been widely adopted for use in  humans14. Body temperature can fluctuate rapidly in these emergency-
care patients and because cooling is recommended as soon as HRI is considered likely, many humans present 
for medical assessment after they have been cooled and therefore their temperature has already begun to drop. 
The Japanese Association for Acute Medicine Heat-Related Illness Classification (JAAMHC) has been pro-
posed as an alternative diagnostic and triage tool for use in human patients with  HRI15. This novel classification 
included clinical symptoms that were more objectively defined, removed the reliance upon body temperature 
and self-reported symptoms as diagnostic criteria, and acknowledged that HRI is a progressive rather than a 
static disorder within patients where increasingly severe pathology is developed with ongoing exposure to heat 
or failure to receive appropriate treatment (available http:// www. mdpi. com/ 1660- 4601/ 15/9/ 1962/ s1)15. Crucially, 
the JAAMHC novel classification appears better at predicting clinical outcomes for human patients with  HRI15,16, 
enabling more appropriate and targeted treatment following initial triage.
Most canine HRI research has applied a variation of the Classical Heat Stroke Criteria when selecting cases for 
analysis, and generally included only dogs presented to referral hospitals rather than primary-care  practices11,17,18. 
This has tended to exclude dogs presenting with milder clinical signs of HRI from inclusion in studies while 
favouring inclusion of severe cases requiring advanced levels of care, resulting in research findings that may 
suffer from referral  bias19. The HRI case fatality rate reported by these earlier referral-based studies ranged from 
36 to 50%11,17,18, whilst a veterinary primary-care study including dogs with all stages of HRI reported a much 
lower case fatality rate of 14%20, highlighting the benefits from primary-care focused research for results that 
are more generalisable to the wider dog population. No specific triggers for HRI were reported in the clinical 
records for almost a third of the dogs presented in the primary-care  study3, potentially demonstrating a lack of 
recognition of early signs of HRI by owners or veterinary professionals. Improved awareness of the triggers of 
HRI, the clinical signs of mild HRI and the actions needed when a dog presents with HRI should be considered 
as urgent educational priorities for both owners and veterinary professionals to protect canine welfare in the face 
of rising global temperatures and increasingly frequent extreme heat  events21,22. Use of the Classical Heat Stroke 
Criteria definitions that rely on body temperature as a diagnostic criterion may promote continued misdiagnosis 
because HRI cases that have already begun to cool may be misclassified. This can result in missed opportunities 
to manage mild or early HRI cases, as noted in human  medicine15. Therefore, the current paper proposed that a 
more objective and staged approach for diagnostic criteria should be explored and then used to develop a more 
reliable HRI clinical grading scheme in dogs.
This study aimed to (i) report the clinical presentations and outcomes of dogs presenting to primary-care 
veterinary clinics in the UK with HRI, and (ii) adapt the JAAMHC novel HRI classification system to develop a 
new clinical grading system that is based on canine first opinion data and therefore more reliable and applicable 
for use in the wider population of dogs. The study is presented in three phases to reflect the sequential nature 
of the work.
Phase 1: reviewing the clinical presentation data of dogs affected by heat‑related 
illness
Data collection and management. This study continues the work previously reported in Hall et al.3,20 
and used the same dataset described in those studies. The VetCompass Programme collects deidentified elec-
tronic patient records (EPRs) from affiliated primary-care veterinary practices in the UK, providing a research 
database for large scale primary-care studies that includes the clinical records of over 9 million  dogs23–26. All 
dogs under veterinary care during 2016 were included in the current study population as previously defined in 
Hall et al.20. Candidate cases for HRI were identified by searching EPRs for the following terms: heat stroke ~ 3, 
heatst*, hyperthermi*, overheat*, over heated ~ 2, heat exhaustion ~ 2, hot car ~ 2, collapse* + heat, cooling, high 
ambient temp*. Candidate cases were manually reviewed by two authors (authors 1 and 2) to identify all dogs 
meeting the case definition of HRI and presenting between 1st January 2016 and 31st December 2018 (see 
Table 1).
All confirmed HRI events underwent additional data extraction including: date of the event, date of pres-
entation, presenting clinical signs, duration of treatment, and outcome (survived or died including euthanasia, 
unknown cause of death and unassisted deaths). For this study, only HRI events occurring between 1st January 
2016 and 31st December 2018 were included in the analysis, as events that occurred prior to 1st January 2016 
resulted in a survival outcome by definition (Fig. 1).
Investigating the relative risk of death associated with clinical signs recorded for HRI 
events. The study included 856 HRI events that occurred between 2016 and 2018 identified from the EPRs 
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of 828 dogs (28 dogs had two HRI events in this period), from a population of 905,543 dogs presenting to 
primary-care veterinary clinics in the UK during 2016. The recorded clinical signs extracted for each HRI event 
were analysed to determine the relative risk of death overall and specifically for unassisted death (see definitions 
below) for dogs showing each individual clinical sign compared to dogs not showing that clinical sign:
• Death by any mechanism (including unassisted death, unknown method of death and euthanasia).
• Unassisted deaths only (deaths via euthanasia or an unrecorded mechanism were excluded).
Events without at least one clinical sign recorded in the EPR were excluded from the relative risk analysis. 
Univariable relative risk analysis using the chi squared test was performed using StatCalc v7.2 (Epi Info, Centre 
for Disease Control and Prevention, https:// www. cdc. gov/ epiin fo/ index. html). Statistical significance was set 
at p < 0.05.
From the 856 HRI events reviewed, 63 events (7.34%) did not have at least one clinical sign recorded and 
were removed from the analysis. From the 793 EPRs with at least one recorded clinical sign, the most commonly 
Table 1.  Case inclusion and exclusion criteria used for heat-related illness (HRI) events in dogs presenting to 
primary-care veterinary practice, defined in Hall et al.20.
Inclusion criteria—Evidence for heat-related illness recorded in the 
patient record
Final stated diagnosis or insurance claim for a heat-related illness 
(including heat stroke, heat stress, heat exhaustion or other synonym),
and/or
History of at least one of the clinical signs listed below, clinical 
records indicated that these were associated with exposure to these 
triggers: exposure to a hot environment, physical exertion or both
Clinical signs
• Panting excessively (panting continues despite removal from heat/
cessation of exercise)
• Collapse not subsequently attributed to another cause (e.g. heart 
failure, Addison’s)
• Stiffness, lethargy or reluctance to move
• Gastrointestinal disturbance including hypersalivation, vomiting or 
diarrhoea
• Neurological dysfunction including ataxia, stupor, seizures, coma 
or death
• Coagulation disturbances (bleeding disorders) including petechiae 
or purpura
Exclusion criteria
Subsequent diagnosis of an infectious or inflammatory condition that 
was not attributed to primary heat exposure such as kennel cough, 
pyometra or infectious meningitis
HRI or synonym listed only as one of a differential list
An earlier diagnosis of HRI that was later revised to exclude HRI, 
for example the dog was diagnosed with epilepsy following further 
seizure activity
Figure 1.  Flow chart of decisions for event inclusion in heat-related illness (HRI) staging analysis and reporting 
clinical presentations of HRI in UK dogs.
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recorded clinical signs were altered respiration (including excessive panting and dyspnoea) (n = 545, 68.73%), 
lethargy (n = 379, 47.79%) and intermittent collapse (n = 250, 31.5%). Multiple clinical signs were recorded for 
560 HRI events (70.6%).
The clinical signs with the highest relative risk of death overall (including euthanasia, unknown method and 
unassisted deaths) are shown in Table 2. Dogs presenting with abnormal mentation (including unresponsive, 
coma, stupor, multiple seizures and status epilepticus), gastrointestinal haemorrhage, petechiae/purpura or 
ataxia had at least three times the relative risk of death compared to dogs presenting without those clinical signs.
The clinical signs with the highest relative risk of unassisted death are shown in Table 3. Dogs presenting 
with abnormal mentation (including unresponsive, coma, profound depression or multiple seizures) also had 
significantly increased risk of an unassisted death (p < 0.001). Dogs with lethargy recorded as a clinical sign for 
their HRI event had a significantly reduced relative risk of death (overall and unassisted) (p < 0.001).
Table 2.  Proportional fatality and relative risk for death overall (including euthanasia, unknown method and 
unassisted) in dogs recorded with specific clinical signs of heat-related illness cases presenting to primary-care 
veterinary practices in the UK between 2016 and 2018. Relative risk describes the risk ratio of death in heat-
related illness cases recorded with this clinical sign compared to cases without this clinical sign. *CI confidence 
interval, n = 793.
Presenting clinical 
sign
Clinical sign recorded Clinical sign not recorded
Relative Risk 95% CI* p-valuen Deaths % Fatality Rate n Deaths % Fatality Rate
Unresponsive 51 43 84.31 742 47 6.33 13.31 9.85 to 17.98 < 0.001
Coma 15 14 93.33 778 76 9.77 9.55 7.42 to 12.30 < 0.001
Stupor 24 17 70.83 769 73 9.49 7.46 5.33 to 10.45 < 0.001
Multiple seizures 12 8 66.67 781 82 10.5 6.35 4.05 to 9.95 < 0.001
Gastrointestinal haem-
orrhage 27 14 51.85 766 76 9.92 5.22 3.43 to 7.97 < 0.001
Petechiae/purpura 18 8 44.44 775 82 10.58 4.2 2.41 to 7.32 < 0.001
Ataxia 14 5 35.71 779 85 10.91 3.27 1.58 to 6.80 0.002
Respiratory (excessive 
panting/dyspnoea) 545 66 12.11 248 24 9.68 1.25 0.80 to 1.95 0.321
Single seizure 30 4 13.33 763 86 11.27 1.18 0.47 to 3.01 0.724
Hypersalivation 33 4 12.12 760 86 11.32 1.07 0.42 to 2.74 0.886
Diarrhoea 76 9 11.84 717 81 11.30 1.05 0.55 to 2.00 0.887
Vomiting 193 22 11.40 600 68 11.33 1.01 0.64 to 1.58 0.980
Collapse-intermittent 250 27 10.80 543 63 11.60 0.93 0.61 to 1.42 0.741
Lethargy 379 21 5.54 414 69 16.67 0.33 0.21 to 0.53  < 0.001
Table 3.  Proportional fatality and relative risk for unassisted death (excluding euthanasia) in dogs recorded 
with specific clinical signs of heat-related illness cases presenting to primary-care veterinary practices in the 
UK between 2016 and 2018. Relative risk describes the risk ratio of death in heat-related illness cases recorded 
with this clinical sign compared to cases without this clinical sign. *CI confidence interval, n = 738.
Presenting clinical sign
Clinical sign present Clinical sign not present
Relative Risk 95% CI* p -valuen Unassisted deaths % Fatality Rate n Unassisted deaths % Fatality Rate
Unresponsive 29 21 72.41 709 14 1.97 36.67 20.84 to 64.54 < 0.001
Coma 9 8 88.89 729 27 3.70 24.00 15.51 to 37.13 < 0.001
Stupor 12 5 41.67 726 30 4.13 10.08 4.74 to 21.47 < 0.001
Multiple seizures 7 3 42.86 731 32 4.38 9.79 3.90 to 24.57 < 0.001
Gastro- intestinal haemorrhage 15 2 13.33 723 33 4.56 2.92 0.77 to 11.07 0.115
Single seizure 29 3 10.34 709 32 4.51 2.29 0.75 to 7.05 0.148
Respiratory (excessive panting/ 
dyspnoea) 508 29 5.71 230 6 2.61 2.19 0.92 to 5.20 0.076
Ataxia 10 1 10.00 728 34 4.67 2.14 0.32 to 14.15 0.429
Petechiae/ Purpura 11 1 9.09 727 34 4.68 1.95 0.29 to 12.98 0.491
Hyper- salivation 31 2 6.45 707 33 4.67 1.38 0.35 to 5.50 0.646
Collapse—intermittent 231 8 3.46 507 27 5.33 0.65 0.30 to 1.41 0.276
Diarrhoea 69 2 2.90 669 33 4.93 0.59 0.14 to 2.40 0.459
Vomiting 176 5 2.84 562 30 5.34 0.53 0.21 to 1.35 0.185
Lethargy 363 5 1.38 375 30 8.00 0.17 0.07 to 0.44 < 0.001
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Investigating the relative risk of death associated with presenting body temperature meas‑
urements for HRI events. Because body temperature at first veterinary presentation is still routinely used 
as a key criterion for clinical management of HRI in many veterinary  settings2,11,12,22, the presenting body tem-
perature of survivors versus non survivors was compared using the Mann-Whitney U test following normality 
testing showing a non-normal distribution of body temperature values. The relative risk of death associated 
with several body temperature thresholds at presentation was explored as part of the development process for 
the current novel VetCompass Clinical Grading Tool for Canine Heat-Related Illness (referred to as the Vet-
Compass HRI Grading Tool hereafter). Three temperature thresholds were compared: < 37.2  °C versus 37.2–
40.9 °C, ≥ 41 °C versus 37.2–40.9 °C, and ≥ 43 °C versus 37.2–42.9 °C. For each HRI event, the presenting body 
temperature was categorised as below, or at/above each of the three thresholds. The relative risk of death overall 
and the relative risk of unassisted death were calculated for each temperature threshold; HRI events where the 
presenting body temperature was not recorded in the EPR were excluded from analysis. Dogs that died as a result 
of euthanasia or unreported mechanisms were excluded from the analysis for relative risk of unassisted death. 
Associations with hypothermia were also explored because hypothermia has been identified previously as a risk 
factor for  death11. The threshold for hypothermia was < 37.2 °C, as defined by Konietschke et al.27. Whilst this 
threshold is lower than the limit (< 37.6 °C) used by Bruchim et al.11, this temperature range was derived from a 
canine population living in a similar climate to the UK.
Body temperature at presentation was recorded for 629 events (73.5%). The median temperature recorded 
for non-survivors (n = 71), was 41.0 °C (IQR: 39.6–42.4 °C, range: 35.6–43.3 °C) (p < 0.001) and was signifi-
cantly higher than for survivors (n = 558) which was 39.6 °C (interquartile range [IQR]: 38.7–40.5 °C, range: 
34.9–43.4 °C). The number of dogs presenting with a body temperature < 37.2 °C, ≥ 41 °C or ≥ 43 °C is shown in 
Table 4. Dogs presenting with a body temperature ≥ 43 °C had a higher relative risk of death and unassisted death 
compared to dogs with a temperature ≥ 41 °C (see Table 4). Dogs presenting with hypothermia (< 37.2 °C) did 
not have a significantly increased relative risk of death (p = 0.256) or unassisted death compared to dogs without 
hypothermia (p = 0.256).
Phase 2: adapting the JAAMHC staging criteria for use in canine HRI patients
The clinical symptoms identified in the JAAMHC staging criteria for human HRI were adapted for application 
to dogs in the current study (see Table 5) to create the novel VetCompass HRI Grading Tool. This adaptation was 
based on differences in physiology between the two species (namely thermoregulatory reliance on panting rather 
than sweating in dogs) and the evidence base generated from the relative risk analysis for presenting clinical signs 
reported above. The clinical signs that were associated with significantly increased risk of death overall and risk 
of unassisted death in the current study (p < 0.05) were included in the most severe category, notably: altered 
mentation (including unresponsive, coma, profound depression, multiple seizures and ataxia) gastrointestinal 
haemorrhage and petechiae/purpura.
Although the current study did not evaluate laboratory diagnostic results, a previous study of post mortem 
findings in dogs that died as a result of HRI reported hepatomegaly in all cases, and hepatic parenchymal necro-
sis in over half the dogs  examined28. Renal pathology was also noted in all the dogs examined, ranging from 
interstitial and glomerular congestion to tubular necrosis in both the proximal and distal convoluted  tubules28. 
Abnormal renal and hepatic function were therefore retained in the diagnostic criteria for severe HRI in dogs.
Phase 3: retrospective grading of 2016–2018 canine HRI events using the novel 
VetCompass grading tool
Analysis. All HRI events identified during 2016–2018 were retrospectively classified according to the novel 
VetCompass HRI Grading Tool defined in Table 5. Where an HRI event had insufficient information recorded 
in the EPR to allow classification, the event was categorised as “unreported” as per the definition in Table 5. 
Descriptive statistics and the distribution of cases were compared with the distribution of human HRI events.
Table 4.  Body temperature at veterinary presentation as a risk factor for death (all causes) and unassisted 
death in dogs diagnosed with heat-related illness presenting to primary-care veterinary practices in the UK 
between 2016 and 2018. Relative risk describes the risk of death in heat-related illness cases meeting each 
temperature criterion compared to cases that did not meet this criterion. *CI confidence interval n = 629 for 
overall death analysis, n = 583 for unassisted death analysis.
Temperature
Clinical sign present Clinical sign not present





< 37.2 °C 14 2 14.29 483 32 6.63 2.16 0.54 to 28.79 0.256
≥ 41 °C 132 37 28.03 483 32 6.63 4.23 2.75 to 6.52 < 0.001









Rate Relative Risk 95% CI p-value
< 37.2 °C 13 1 7.70 460 9 1.96 3.93 0.54 to 28.79 0.256
≥ 41 °C 110 15 13.64 460 9 1.96 7.06 3.17 to 15.71 < 0.001
≥ 43 °C 12 7 58.33 558 17 3.05 19.15 9.81 to 37.39 < 0.001
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The utility of temperature thresholds was explored within the VetCompass HRI Grading Tool. The inclusion 
of temperature threshold ≥ 43 °C as a severe grade criterion within the VetCompass HRI Grading Tool would 
have changed the grading of three events: one originally graded mild would have changed to severe and two 
events originally graded moderate would have changed to severe. None of these events resulted in fatality, and 
only one of the three events resulted in hospitalisation beyond one day. This suggests limited additional value 
from adding a temperature threshold ≥ 43 °C as a severe grade criterion to the grading tool.
The inclusion of temperature threshold ≥ 41 °C as a severe grade criterion within the VetCompass HRI Grad-
ing Tool would have changed the grading of 83 (9.70%) of the 856 events; 40 (12.62%) of the 317 events originally 
graded mild would have changed to severe, and 43 (11.75%) of the 366 events originally graded moderate would 
have changed to severe. From the 40 events originally graded mild, there was one fatality, an elderly animal the 
owners elected to euthanise. From the 43 dogs originally graded moderate, there were four fatalities—three of 
which were unassisted deaths. Of these four dogs, one elderly dog was euthanised due to underlying laryngeal 
paralysis, one of the unassisted deaths was a dog that had experienced multiple HRI events that year and died 
under sedation, the remaining two dogs were brachycephalic one of which experienced a cardiac arrest and the 
other died following a tracheostomy. There were an additional 17 events that resulted in hospitalisation beyond 
one day, however all these events were discharged after one overnight stay.
This review suggests that the application of temperature thresholds add little additional value to the grading 
tool and therefore body temperature was omitted from the final VetCompass HRI Grading Tool definitions, in 
line with similar recommendations from Yamamoto et al.14 for human HRI patients.
The distribution of HRI event severity using the novel VetCompass grading tool. The distribu-
tion of HRI events using the VetCompass HRI Grading Tool is shown in Fig. 2. Overall, 39.92% of classified 
Table 5.  Development of the novel VetCompass Clinical Grading Tool for Heat-Related Illness in dogs, based 
upon the JAAMHC human heat-related illness scale.
Japanese Association of Acute Medicine 
Heat-Related Illness Classification stages Human symptoms
VetCompass Clinical Grading Tool for 
Heat-Related Illness in dogs grades Adapted canine clinical signs
Stage I
Dizziness, faintness, slight yawning
Heavy sweating
Muscle pain, stiff muscles (muscle cramps)
Impaired consciousness is not observed
Mild
No impaired consciousness observed
Lethargy or stiffness




Declined concentration and judgement
Moderate





Includes at least one of the following:
Central nervous system manifestation 





Includes at least one of the following:
Central nervous system impairment (ataxia, 
two or more seizures, profound depression, 
unresponsive, coma)




Unreported N/A Unreported No clinical signs or diagnostic results recorded in the clinical history
Figure 2.  The event distribution and survival outcomes for HRI grades defined using the VetCompass Clinical 
Grading Tool for Heat-Related Illness in dogs presenting to primary-care veterinary practices in the UK 
between 2016 and 2018.
7
Vol.:(0123456789)
Scientific Reports |         (2021) 11:6828  | https://doi.org/10.1038/s41598-021-86235-w
www.nature.com/scientificreports/
HRI events were graded mild, 46.10% graded moderate and 13.98% graded severe. In comparison, the distri-
bution of human HRI events presenting to 102 Japanese hospitals during the summer of 2012 classified by the 
JAAMHC in one paper was 48.86% stage I, 33.24% stage II and 17.90% stage  III15. The distribution of canine HRI 
events between the grades of the VetCompass HRI Grading Tool closely reflected the distribution in human HRI 
patients reported by Yamamoto et al.15.
Comparing the fatality rate distribution of canine versus human HRI events. The fatality rate 
(death overall) for canine HRI events classified using the novel VetCompass HRI Grading Tool was 2.21% for 
mild events, 5.46% for moderate events and 56.76% for severe events. The unassisted death fatality rate increased 
from 0.32% in mild events, to 2.19% in moderate events, and 23.42% in severe events.
These fatality rates compare to the findings of a human study using the JAAMHC classification for human 
HRI events: stage I patients all survived, the fatality rate for stage II patients was 0.7%, increasing to 10.2% for 
stage III  patients15.
The final VetCompass HRI grading tool. The final VetCompass Clinical Grading Tool for HRI in dogs 
(Fig. 3) incorporated clinical signs but excluded presenting body temperature as a defining criteria. Although 
a presenting body temperature ≥ 41 °C and ≥ 43 °C were both associated with a significantly increased relative 
risk of death compared to dogs presenting with lower body temperature, it is the duration of temperature eleva-
tion that results in clinical pathology, so a single temperature reading alone is poorly diagnostic of severe illness 
unless that temperature is above 45 °C13. Clinical management should aim to prevent worsening of the patient’s 
condition through early temperature management, fluid therapy and supportive management of body systems 
 affected29,30.
Ethics approval. Ethics approval was granted by the RVC Ethics and Welfare Committee (reference num-
ber SR2018-1652). This project used only data from a research repository, no actual dogs were involved in the 
project.
Discussion
This study reports that the most commonly recorded clinical signs in UK dogs with HRI presenting to primary-
care veterinary practices were respiratory changes (excessive panting/dyspnoea) and lethargy. This is a key finding 
to assist dog owners, as early recognition of these milder clinical signs could allow them to take earlier action to 
prevent worsening of their pet’s condition and prevent progression of the HRI. We also report that the clinical 
signs associated with the highest relative risk of death (both overall and unassisted) were abnormal mentation 
including unresponsive, coma, stupor and multiple seizures (including status epilepticus). The results from 
Figure 3.  The novel VetCompass clinical grading tool for heat-related illness in dogs.
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relative risk analysis were applied as an evidence base to support an adaptation of the JAAMHC classification 
for human HRI events to create the novel VetCompass Clinical Grading Tool for HRI in dogs.
Previous veterinary studies of HRI in dogs have tended to focus on the most severe subset of cases, using 
the Classical Heat Stroke Criteria heat stroke definition to determine case inclusion  criteria11,18,31. These studies 
were generally restricted to dogs referred for specialist care, and so are poorly representative of the overall canine 
population. For this reason, we elected to compare the distribution of canine HRI events in the current study to 
the distribution of human HRI events reported in a study from  Japan15 rather than to previously reported studies 
in dogs. The progressive nature of HRI should theoretically result in the majority of HRI events being classed 
as stage I, with fewer events classed as stage II, and the minority of events progressing to stage III, especially as 
public awareness of HRI has increased the likelihood of early interventions such as cooling and removal from 
hot  environments32. More canine HRI events were classified as moderate than mild compared to the human 
results, which may represent a variety of owner-related factors. Increased public awareness of HRI through 
national campaigns may have resulted in more owners managing milder cases at home rather than seeking active 
veterinary care. The impacts from financial costs of veterinary consultation may also play a role here: owners 
may preferentially present more severe cases for veterinary care because they perceive the clinical risk justifies 
the financial outlay whereas they may choose to monitor and manage milder cases on their own. This could 
drive a relative underreporting of milder HRI in UK dogs. It is also possible that some owners either did not 
recognise mild HRI events, or as suggested by Packer et al.33, brachycephalic owners may in fact perceive mild 
HRI as “normal for their breed of dog”.
The clinical signs included in the Grading Tool for severe HRI reflect the pathological findings reported 
in a study of 11 dogs that died (ten unassisted deaths and one euthanasia) as a result of HRI in one referral 
 hospital28, namely evidence of a coagulopathy, gastro-intestinal mucosal necrosis, renal damage, hepatopathy 
and brain damage. The presence of petechiae/purpura suggests a coagulopathy had developed, a consequence 
of endothelial damage from both thermal injury to cells and also secondary hypoperfusion, shock and systemic 
inflammatory  response1,28. Disseminated intravascular coagulopathy (DIC) is a life threatening syndrome that 
occurs when widespread activation of the coagulation system is triggered alongside dysregulation of thrombin 
generation (e.g. a hypercoagulable to a hypocoagulable state)34. Heat-related illness can trigger DIC, as reported 
by Bruchim et al. where all of the dogs examined post mortem were found to have developed DIC as a result of 
their  HRI28. A mortality rate of 62.5% has been reported for dogs with overt DIC (three or more coagulation 
variable abnormalities detected during clinical screening) triggered by a variety of inciting disorders including 
 HRI35. It is therefore appropriate that the clinical signs of petechiae/purpura were included in the criteria for 
severe HRI in dogs, as it is for  humans14.
Histopathological examination of the brains and meninges of dogs that died as a result of HRI revealed mild 
to severe oedema and hyperaemia in all sections examined from all dogs in the previous  study28. In another 
study of dogs presenting to a referral hospital with HRI, cases presenting with profoundly altered mentation 
(obtunded or comatose) had a fatality rate of 70%, and the dogs that presented with disorientation or stupor had 
a fatality rate of 41%11. In the present study, all clinical signs indicative of altered mentation had a significantly 
increased relative risk of both death overall and unassisted death, and are therefore included in the severe HRI 
criteria in the current grading tool.
Altered respiration was the most frequently recorded clinical sign for all dogs with HRI in the present study. 
Pulmonary oedema and hyperaemia were noted in all the deceased dogs examined at post mortem by Bruchim 
et al.28, and tachypnoea was reported in around 80% of the dogs presented to the same referral hospital with heat 
 stroke11. However, altered respiration including panting heavily or respiratory distress, was not associated with 
an increased relative risk of death or unassisted death in the present study. As panting is a key thermoregulatory 
mechanism in dogs for cooling, this clinical sign will be present in all conscious dogs with hyperthermia at some 
point during a HRI event and is therefore included in the criteria for mild HRI in the grading tool. Comatose 
dogs cease panting, which likely contributes to their reduced rate of cooling when immersed in cold  water36, and 
potentially contributes to the increased fatality rate in dogs that developed impaired mentation as a result of HRI.
The findings of the present study support the recommendations of recent human HRI  studies14,15 that body 
temperature should no longer be considered a reliable diagnostic criterion for staging HRI in dogs. Body 
temperature can fluctuate rapidly, especially when active cooling methods have been applied prior to clinical 
 assessment37. There are also conflicting results on the associations between body temperatures per se and patho-
logical changes in dogs. In a study of anaesthetised dogs, prolonged (90 min) whole body hyperthermia at 42.5 °C 
failed to induce histopathological or clinically significant neurological disturbance, when other physiological 
responses to hyperthermia (for example respiratory alkalosis or reduced blood pressure) were  prevented38. Post 
exercise body temperatures of 42.5 °C have also been reported in dogs showing no clinical signs of  HRI39,40. 
Experimental heat stroke studies carried out on dogs in the 1970s suggested that 43 °C is the critical tempera-
ture threshold for canine  HRI13. In a series of inhumane experiments that involved exposing dogs to ambient 
temperatures of 50 °C both with and without physical exertion until they collapsed, a body temperature of 43 °C 
was reported as the critical limit for clinical effects. Dogs that did not exceed a body temperature of 43 °C had 
no clinical or clinicopathological signs of HRI, whilst dogs that developed a body temperature > 44 °C all died 
of heat stroke. The longer a dog had a body temperature > 43 °C, the greater the likelihood of death. The previ-
ously proposed critical body temperature threshold of > 41 °C for diagnosis of HRI can therefore no longer be 
considered appropriate. Any dog with a temperature approaching 41 °C should be actively cooled as a matter of 
urgency, but clinical signs should be used to then determine the severity of HRI present.
Hypothermia on presentation has previously been reported as being associated with an increased fatality 
 rate18. However, Drobatz and  Macintire18 clarified that it was not possible to determine if hypothermia due 
to cooling contributed to the poor outcome, or if hypothermia was instead an effect of poor tissue perfusion 
caused by profound clinical disease. In the present study, hypothermia on presentation was not associated with 
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an increased risk of death overall or unassisted death, reflecting the findings of Bruchim et al.11. Many veterinary 
texts caution against aggressive, rapid cooling of dogs with HRI due to a perceived hazard of  hypothermia41–43. 
However, from the current study, it appears hypothermia does not increase the fatality risk for dogs. In humans 
with exertional HRI, cold water immersion is the gold standard  treatment44. Rapid (within minutes of collapse) 
initiation of cooling using cold (10 °C) water immersion until the patient’s body temperature dropped below 
38.8 °C was associated with 100% survival rate in one study of over 200 HRI  events37. In dogs, work to date has 
included the use of warm water (30 °C) immersion to effectively cool dogs with exertional hyperthermia but 
not  HRI45, and dogs with experimentally induced HRI cooled with a range of water  temperatures36. The latter 
study reported that tap water (15–16 °C) achieved the fastest rate of cooling in conscious dogs with HRI, but 
found that comatose dogs cooled at a slower rate due to the cessation of  panting36. As drowning is a risk to any 
HRI patient undergoing water immersion, especially patients with central nervous system impairment, constant 
monitoring is needed to ensure the head remains above the water  level29,44.
A novel severity scoring system has been proposed previously for dogs with HRI by Segev et al.46. However, 
that scoring system required comprehensive laboratory analysis including prothrombin and activated partial 
thromboplastin time, blood glucose, biochemistry, and haematology analysis, and required the use of a statistical 
model to determine the overall patient score. This reliance on laboratory tests requires the dog to be physically 
presented to the veterinary practice in order to take the samples, and the owners to be both willing and able 
to pay for the tests before the score can be determined. As noted in that study’s limitations, the scoring system 
proposed by Segev et al. is aimed at assisting decision making for only the most severe of cases, and requires 
further testing before it can be deemed a reliable  model46.
In contrast, the novel VetCompass HRI Grading Tool proposed in the present study aimed to create a grading 
system that could be used by veterinary professionals to triage patients over the telephone or when presenting 
to the veterinary practice, and that can be used without the need for complex statistical modelling, potentially 
expensive laboratory testing or indeed any mathematical calculations. The tool could be displayed as a poster 
(see Fig. 3) in veterinary receptions, and be added to the emergency or treatment room as a quick reference guide 
to assist veterinary staff with decision making and provide advice to owners regarding a potential prognosis for 
dogs with HRI. It could be adapted as an educational tool to improve public awareness of the early signs of HRI 
in dogs, to be shared on social media to get to the attention of owners who are the key decision-makers in the 
early phases of most dogs with HRI. Delayed cooling has been associated with an increased fatality rate in dogs 
presenting to a referral hospital with  HRI11, thus improving owners’ ability to recognise and promptly respond 
to signs of HRI in dogs should be considered a priority as global temperatures continue to rise.
This study had some limitations. As noted in previous studies, VetCompass clinical record data are not 
recorded for research  purposes3,20. As a result, there are missing data within the dataset and descriptive data 
may be inaccurate or incomplete, because they are reliant upon the history recorded by the attending veterinary 
surgeon and so can be impacted by factors such as stress and workload, especially when recording clinical notes 
from emergency patient presentations. For events with an unassisted death, progressive changes in clinical signs 
may not have been accurately recorded within the electronic clinical history but may instead have been recorded 
on alternative documentation such as paper-based hospital records or cardiac arrest monitoring charts. Like-
wise, HRI cases that were euthanised may have limited clinical histories and clinical signs recorded if the owner 
requested euthanasia early during presentation. Some cases may also have been euthanised before additional 
clinical signs developed if there were financial constraints on treatment options, or if the dog was elderly or had 
other underlying health conditions that contributed to the decision to euthanise.
Future evaluation may help to refine the VetCompass HRI Grading Tool further by exploring the tool’s pre-
dictive ability for other HRI factors such prolonged hospitalisation and dog conformations.
Conclusion
This study presents the novel VetCompass Clinical Grading Tool developed for dogs with heat-related illness, 
and aims to improve both owner and veterinary recognition of the progressive clinical signs associated with the 
disorder. Continued use of the previously available Classical Heat Stroke Criteria should be done with caution 
because those criteria were not designed for use with canine patients. There is a risk of underestimating the 
severity of the dog’s condition due to a reliance on patient reported symptoms and presenting body temperature 
rather than observed clinical signs. Continued use of body temperature as a diagnostic criterion cannot be sup-
ported, in line with recent human medical advances. The VetCompass HRI Grading Tool offers a quick, practical 
and evidence-based tool for veterinary professionals to grade HRI cases and should assist in optimising clinical 
care and the clinical outcomes. As global temperatures continue to rise, uncomplicated triage tools such as the 
one proposed in this study can help to improve owner understanding and assist in decision making for effective 
early management when HRI occurs.
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